ROCKET PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements
15 Contracts & Agreements
- Offer Letter, dated March 25, 2024 by and between the registrant and Aaron Ondrey (Filed With SEC on May 7, 2024)
- PROPRIETARY INFORMATION, INVENTIONS AND NON-SOLICITATION/NON-COMPETITION AGREEMENT (Filed With SEC on February 27, 2024)
- Offer Letter, dated April 29, 2021, by and between the registrant and Isabel Carmona (Filed With SEC on February 28, 2022)
- Offer Letter, dated September 29, 2017, by and between the Registrant and Raj Prabhakar (Filed With SEC on February 28, 2022)
- Offer Letter, dated November 25, 2020, by and between the registrant and Carlos Garcia-Parada (Filed With SEC on March 1, 2021)
- Description of Securities (Filed With SEC on March 1, 2021)
- Offer Letter, dated September 25, 2019, by and between the registrant and Kamran Alam (Filed With SEC on March 6, 2020)
- Letter Agreement, dated as of January 4, 2018, by and between Inotek Pharmaceuticals Corporation and Dale Ritter (Filed With SEC on March 7, 2018)
- Amendment to Offer Letter, effective as of September 12, 2017, by and between Inotek and Rudolf A. Baumgartner, MD (Filed With SEC on September 13, 2017)
- Amendment to Offer Letter, effective as of September 1, 2017, by and between the Company and David Southwell (Filed With SEC on September 1, 2017)
- Amendment to Offer Letter, effective as of September 1, 2017, by and between the Company and Dale Ritter (Filed With SEC on September 1, 2017)
- AMENDMENT TO OFFER LETTER (Filed With SEC on August 8, 2017)
- Additional abbreviations may also be used though not in the above list. For Value Received, hereby sell, assign and transfer unto (Filed With SEC on March 31, 2015)
- INOTEK PHARMACEUTICALS CORPORATION AMENDMENT NO. 1 TO THE THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on November 5, 2014)
- THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on November 5, 2014)
